This classifier comprises 82 CNS tumor methylation classes and uses the information on methylation status (e.g., IDH status) as well as copy number changes (e.g., 1p19q co-deletion) to classify the tumors. This evidence concerns the gene IDH1 and central nervous system neoplasm.